Simulations Plus

Simulations Plus Current Liabilities

The Current Liabilities of Simulations Plus (SLP) as of Sep 27, 2026 is 5.81 M USD. In the previous year, Current Liabilities was 14.91 M USD — a change of -61.02% (lower).

Current Liabilities

5.81 MUSD

YoY

-61.02%

Last updated:

Current Liabilities of Simulations Plus is 2026 5.81 M USD. Current Liabilities of Simulations Plus was 2025 14.91 M USD. It decreases by -61.02% lower compared to the previous year.

The Simulations Plus Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
7.82 M USD
Jan 1, 2019
-759.91 M USD
Jan 1, 2020
7.76 M USD
Jan 1, 2021
15.91 M USD
Jan 1, 2022
8.08 M USD
Jan 1, 2023
13.58 M USD
Jan 1, 2024
14.91 M USD
Jan 1, 2025
5.81 M USD
The Simulations Plus Current Liabilities history
YEARCurrent LiabilitiesYoY
5.81 MUSD-61.02%
14.91 MUSD+9.75%
13.58 MUSD+68.11%
8.08 MUSD-49.22%
15.91 MUSD+104.93%
7.76 MUSD-101.02%
-759.91 MUSD-9,821.11%
7.82 MUSD+187.51%
2.72 MUSD-212.89%
-2.41 MUSD-133.53%
7.18 MUSD-100.96%
-745.29 MUSD+148.21%
-300.26 MUSD-31,692.81%
950,421.00USD-25.29%
1.27 MUSD-17.51%
1.54 MUSD-5.79%
1.64 MUSD+9.44%
1.50 MUSD-12.20%
1.70 MUSD-7.64%
1.84 MUSD+54.98%
1.19 MUSD+13.79%
1.05 MUSD+0.37%
1.04 MUSD-22.85%
1.35 MUSD-12.71%
1.55 MUSD+0.15%
1.54 MUSD+13.04%
1.37 MUSD+52.51%
896,131.00USD+57.50%
568,967.00USD-43.10%
1.00 MUSD+100.00%
500,000.00USD—
Access this data via the Eulerpool API

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Current Liabilities of Simulations Plus is 5.81 M USD in 2026.

Current Liabilities of Simulations Plus changed from 14.91 M USD to 5.81 M USD, representing a -61.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Simulations Plus

All Key Metrics — Simulations Plus